Terzolo, Massimo

Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors

Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsPituitary Gland Disorders and Treatments

Cited by 1,566

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

Bovio, S., Cataldi, A., Reimondo, G., Sperone, P., Novello, S., Berruti, A., Borasio, P., Fava, C., Dogliotti, L., Scagliotti, G. V., et al. (2006) · Journal of Endocrinological Investigation

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 712

Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: Proposal for a Revised TNM Classification

Fassnacht, M., Johanssen, S., Quinkler, M., Bucsky, P., Willenberg, H. S., Beuschlein, F., Terzolo, M., Mueller, H., Hahner, S., Allolio, B., et al. (2009) · Cancer

Adrenal and Paraganglionic TumorsRenal cell carcinoma treatment

Cited by 695

Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors

Arlt, W., Biehl, M., Taylor, A. E., Hahner, S., Libé, R., Hughes, B. A., Schneider, P., Smith, D. J., Stiekema, H., Krone, N., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsMetabolomics and Mass Spectrometry Studies

Cited by 458

Adrenal incidentaloma: a new cause of the metabolic syndrome?

Terzolo, M., Pia, A., Alì, A., Osella, G., Reimondo, G., Bovio, S., Daffara, F., Procopio, M., Paccotti, P., Borretta, G., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 322

Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group

Angeli, A., Osella, G., Ali, A., & Terzolo, M. (1997) · Hormone Research

Adrenal and Paraganglionic TumorsNeuroendocrine Tumor Research Advances

Cited by 259

Long-term follow-up in adrenal incidentalomas: an Italian multicenter study

Morelli, V., Reimondo, G., Giordano, R., Della Casa, S., Policola, C., Palmieri, S., Salcuni, A. S., Dolci, A., Mendola, M., Arosio, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 223

Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas)

Osella, G., Terzolo, M., Borretta, G., Magro, G., Alí, A., Piovesan, A., Paccotti, P., & Angeli, A. (1994) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 206

Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study

Deutschbein, T., Reimondo, G., Di Dalmazi, G., Bancos, I., Patrova, J., Vassiliadi, D. A., Nekić, A. B., Debono, M., Lardo, P., Ceccato, F., et al. (2022) · The Lancet Diabetes & Endocrinology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 205

Subclinical Cushing’s syndrome in adrenal incidentalomas

Terzolo, M., Bovio, S., Reimondo, G., Pia, A., Osella, G., Borretta, G., & Angeli, A. (2005) · Endocrinology and Metabolism Clinics of North America

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 179

Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study

Hermsen, I. G., Fassnacht, M., Terzolo, M., Houterman, S., den Hartigh, J., Leboulleux, S., Daffara, F., Berruti, A., Chadarevian, R., Schlumberger, M., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 173

Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly

Daffara, F., De Francia, S., Reimondo, G., Zaggia, B., Aroasio, E., Porpiglia, F., Volante, M., Termine, A., Di Carlo, F., Dogliotti, L., et al. (2008) · Endocrine Related Cancer

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 167

Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement

Chortis, V., Taylor, A. E., Schneider, P., Tomlinson, J. W., Hughes, B. A., O'Neil, D. M., Libé, R., Allolio, B., Bertagna, X., Bertherat, J., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 154

Effects of SGLT2 inhibitors and GLP-1 receptor agonists on renin-angiotensin-aldosterone system

Puglisi, S., Rossini, A., Poli, R., Dughera, F., Pia, A., Terzolo, M., & Reimondo, G. (2021) · Frontiers in Endocrinology

Renin-Angiotensin System StudiesDiabetes Treatment and Management

Cited by 143

Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection

Terzolo, M., Baudin, A. E., Ardito, A., Kroiss, M., Leboulleux, S., Daffara, F., Perotti, P., Feelders, R. A., deVries, J. H., Zaggia, B., et al. (2013) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 134

Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis

Pelsma, I. C. M., Fassnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 130

Validation of the prognostic role of the “Helsinki Score” in 225 cases of adrenocortical carcinoma

Duregon, E., Cappellesso, R., Maffeis, V., Zaggia, B., Ventura, L., Berruti, A., Terzolo, M., Fassina, A., Volante, M., & Papotti, M. (2017) · Human Pathology

Adrenal and Paraganglionic TumorsRenal cell carcinoma treatment

Cited by 98

Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma

Terzolo, M., Bovio, S., Pia, A., Conton, P. A., Reimondo, G., Dall’Asta, C., Bemporad, D., Angeli, A., Opocher, G., Mannelli, M., et al. (2005) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsHormonal Regulation and Hypertension

Cited by 89

Screening of Cushing’s syndrome in adult patients with newly diagnosed diabetes mellitus

Reimondo, G., Pia, A., Allasino, B., Tassone, F., Bovio, S., Borretta, G., Angeli, A., & Terzolo, M. (2007) · Clinical Endocrinology

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 89

Screening of Cushing’s syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy

Terzolo, M., Reimondo, G., Chiodini, I., Castello, R., Giordano, R., Ciccarelli, E., Limone, P., Crivellaro, C., Martinelli, I., Montini, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 89

Subclinical Cushing's syndrome.

Terzolo, M., Reimondo, G., Bovio, S., & Angeli, A. (2004) · Pituitary

Adrenal and Paraganglionic TumorsPituitary Gland Disorders and Treatments

Cited by 80

Ribonucleotide Reductase Large Subunit ( RRM1 ) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer

Volante, M., Terzolo, M., Fassnacht, M., Rapa, I., Germano, A., Sbiera, S., Daffara, F., Sperone, P., Scagliotti, G., Allolio, B., et al. (2012) · Clinical Cancer Research

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 69

Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status

Scillitani, A., Battista, C., Chiodini, I., Carnevale, V., Fusilli, S., Ciccarelli, E., Terzolo, M., Oppizzi, G., Arosio, M., Gasperi, M., et al. (2003) · Clinical Endocrinology

Pituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth Factors

Cited by 63

Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model

Zatelli, M. C., Gentilin, E., Daffara, F., Tagliati, F., Reimondo, G., Carandina, G., Ambrosio, M. R., Terzolo, M., & degli Uberti, E. C. (2010) · Endocrinology

Thyroid Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 57